Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions

NACompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

March 12, 2022

Study Completion Date

March 12, 2022

Conditions
Weight Change, BodySmoking Cessation
Interventions
BEHAVIORAL

Weight gain prevention (Group 1)

"Participants will be asked to keep their weight stable during the initial 8 weeks of the study.~Intervention Components:~1. Lesson materials adapted from the Small Changes intervention, which will provide guidance for meeting the goals of this intervention (i.e., increasing steps by 2000 steps per day, making one Small dietary Change each day).~2. Daily self-monitoring of steps and number of Small Changes~3. Daily weight self-monitoring on the BodyTraceTM e-scale~4. Fit Bit Alta activity trackers to self-monitor steps"

BEHAVIORAL

Weight loss intervention (Group 2)

"Participants will be asked to achieve a weight loss goal of at least 5% of their baseline weight by week 8.~Intervention Components:~1. Tailored calorie and fat goals based on their baseline weight.~2. Daily dietary intake and physical activity self-monitoring using a website or app.~3. Daily weight self-monitoring on the BodyTraceTM e-scale~4. Lesson materials for each session, drawn from the Look AHEAD intensive lifestyle intervention~5. Meal replacements for two meals and one snack for 8 weeks as a method to achieve the study's calorie and fat goals and as a strategy to control portions~6. Graded physical activity goals of 175 minutes of moderate intensity exercise (e.g., brisk walking) per week, or 10,000 steps per day~7. Fit Bit Alta activity trackers to self-monitor steps"

BEHAVIORAL

Self-guided intervention (Group 3)

"Participants randomized to Group 3 will wait for 8 weeks before initiating the same smoking cessation intervention as the other two conditions, while they review the provided weight management focused book.~Intervention Components:~1. EatingWell Diet book.~2. Daily weight self-monitoring on the BodyTraceTM e-scale"

Trial Locations (1)

38105

University of Tennessee Health Science Center, Memphis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Tennessee

OTHER

NCT03156660 - Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions | Biotech Hunter | Biotech Hunter